FDA Releases Final Guidance on Data Integrity and Compliance With Drug CGMP: Questions and Answers

Summary

The FDA has announced the availability of a final guidance to clarify the role of data integrity in current good manufacturing practice for drugs, following an increase in data integrity lapses in recent inspections, and to help firms implement effective strategies to manage their data integrity risks.